Tuesday, 11 May 2010

Solutions for Applying Automation to Next-Generation Sequencing Sample Prep

FYI might be useful for some.
disclaimer: I am not affliated with the companies involved.

Solutions for Applying Automation to Next-Generation Sequencing Sample Prep

In recent years, next-generation sequencing (NGS) technologies have rapidly evolved to provide faster, better, cheaper and more reliable mapping of DNA and RNA sequences thus enabling a diverse set of genomic discoveries. This has been largely driven by innovations and improvisations at the technical end. However, challenges still remain with increasing sample throughput, enabling sample preparation, minimizing errors, and with improving data analysis.
This webinar provides the audience with an overview of the developments in NGS technologies, with an emphasis on the challenges that are routinely encountered at various stages in the sequencing and analysis of samples. It offers detailed information on the specific challenges associated with sample preparation and the benefits of using automation to alleviate some of the bottlenecks. The webinar features viewpoints expressed by three experts in the field, who share examples from their laboratories on how to effectively adopt and utilize automation for NGS applications.

What will be covered:

  • Overview of NGS technologies and potential challenges in their adoption and use
  • Tackling challenges associated specifically with sample prep for NGS
  • Effective use of automation for alleviating some of the bottlenecks in sequencing
  • Ways to increase and improve the sample throughput in sequencing
  • Use and creation of high-diversity sequencing libraries
  • Application of automated NGS platforms in areas like cancer genetics and CNS research
  • Overview of targeted resequencing applications including effective whole exon sequencing, indexed/barcoded resequencing of small regions, automated targeted resequencing

Who will benefit from attending:

  • Scientists involved in pharmaceutical/biotechnology R&D and clinical services
  • Scientists keen to learn more about the use and adoption of NGS technologies
  • Scientists and clinicians active in biomarker research
  • Scientists looking to use sequencing for oncology and CNS research

Panelists include

  • Shawn Levy, Ph.D., Faculty Investigator, HudsonAlpha Institute for Biotechnology
  • Brian Minie, Ph.D., Broad Institute of MIT and Harvard
  • Emily Leproust, Ph.D., Director, Applications and Chemistry R&D, Genomics, Agilent Technology
John Sterling, Editor in Chief, Genetic Engineering & Biotechnology News, will be the host of this webinar.   A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.

No comments:

Post a Comment

Datanami, Woe be me